Risk of thiazolidinedione-associated fracture should be appropriately assessed.

摘要

In the August 10/24 issue of the Archives, Dormuth et al reported an increased fracture rate in provin-cially insured residents of British Columbia, Canada, exposed to thiazolidinediones between January 1998 and December 2007. We wish to comment on several statements in the article.